Stocktoria

Cytek Biosciences, Inc. CTKB

Nasdaq · stock · Laboratory Analytical Instruments · website · IPO 2021-07-23 · LEI

Cytek Biosciences, Inc. statistics & valuation

Market cap$578.6M
P / S2.9×
P / B1.7×
Net margin-33.0%
Return on equity-19.5%
FCF margin-4.4%
Return on capital-10.5%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
20.90% 2.40% 1.50% -6.30% -3.00% -33.00% 202020212022202320242025
Gross margin (%)
55.70% 61.90% 61.60% 56.70% 55.40% 51.80% 202020212022202320242025
Operating margin (%)
14.70% 7.20% -1.10% -14.40% -10.20% -20.00% 202020212022202320242025
Return on equity (%)
0.70% 0.60% -3.10% -1.50% -19.50% 202020212022202320242025
Shares outstanding
32.6M 133.7M 138.6M 135.3M 130.6M 128.6M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
8.80% 0.70% 0.50% -2.50% -1.20% -14.40% 202020212022202320242025
Free cash flow margin (%)
14.70% 0.20% -13.40% 0.30% 10.90% -4.40% 202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
$0.10 $0.00 $0.02 -$0.09 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Gross margin51.8%55.4%56.7%61.6%61.9%55.7%
Operating margin-20.0%-10.2%-14.4%-1.1%7.2%14.7%
Net margin-33.0%-3.0%-6.3%1.5%2.4%20.9%
FCF margin-4.4%10.9%0.3%-13.4%0.2%14.7%
Return on assets-14.4%-1.2%-2.5%0.5%0.7%8.8%
Return on equity-19.5%-1.5%-3.1%0.6%0.7%-121.1%
Current ratio5.045.866.979.2613.017.86

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.